The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat

2001 ◽  
Vol 442 (4) ◽  
pp. 505-510 ◽  
Author(s):  
Cecilia Odlind ◽  
Ilkka Reenilä ◽  
Pekka Männistö ◽  
Jonas Ekblom ◽  
Peter Hansell
2019 ◽  
Vol 8 (8) ◽  
Author(s):  
Shaoxiong Wang ◽  
Xiaorong Tan ◽  
Peng Chen ◽  
Shuo Zheng ◽  
Hongmei Ren ◽  
...  

Hypertension ◽  
2014 ◽  
Vol 64 (suppl_1) ◽  
Author(s):  
Weili Wang ◽  
Wei-Qing Han ◽  
Qing Zhu ◽  
Imad Damaj ◽  
Pin-Lan Li ◽  
...  

Although there are extensive studies on the regulation of renal sodium excretion by adrenergic pathway, the role of cholinergic pathway in the renal sodium excretion is largely unknown. The present study characterized the expression of α7 nicotinic acetylcholine receptor (nAChR) in the kidneys and determined the functional role of this nAChR subtype in urinary sodium excretion in Sprague Dawley rats. RT-PCR and Western blot analyses showed that α7 nAChR was present in the kidneys. Immunohistochemistry analysis demonstrated that the strongest immunostaining of α7 nAChR was observed in the distal tubules and collecting ducts in the kidneys. Infusion of an α7 nAChR agonist PNU-282987 (2.7 μM, 10 μl/min) into the renal medulla dramatically increased the urine volume (from 15.4 ± 2.1 to 42.5 ± 3.9 μl/min/g kwt) and sodium excretion (from 1.26 ± 0.18 to 4.15 ± 0.60 μmole/min/g kwt), which was blocked by an α7 nAChR antagonist methyllycaconitine (MLA, 5 μM, 10 μl/min), in anesthetized rats. Infusion of PNU-282987 did not cause any change in renal medullary blood flow as measured by Laser Doppler flowmeter. In addition, intra-renal medullary infusion of MLA (5 μM, 10 μl/min) significantly inhibited the volume expansion-induced increase of urine volume and sodium excretion by 25%. These data suggest that activation of renal medullary α7 nAChR produces a natriuretic effect through its tubular action in rats. (Supported by NIH grant HL89563 and HL106042)


2016 ◽  
Vol 28 (4) ◽  
Author(s):  
A. V. Kutina ◽  
D. V. Golosova ◽  
A. S. Marina ◽  
E. I. Shakhmatova ◽  
Y. V. Natochin

1971 ◽  
Vol 68 (1_Suppl) ◽  
pp. S279-S294 ◽  
Author(s):  
Paul Robel

ABSTRACT Of the information available on steroid hormone metabolism in responsive tissues, only that relating hormone metabolism to physiological activity is reviewed, i. e. metabolite activity in isolated in vitro systems, binding of metabolites to target tissue receptors, specific steroid hormone metabolizing enzymes and relationship of hormone metabolism to target organ physiological state. Further, evidence is presented in the androgen field, demonstrating 5α-reduced metabolites, formed inside the target cells, as active compounds. This has led to a consideration of testosterone as a »prehormone«. The possibility that similar events take place in tissues responding to progesterone is discussed. Finally, the role of hormone metabolism in the regulation of hormone availability and/or renewal in target cells is discussed. In this context, reference is made to the potential role of plasma binding proteins and cytosol receptors.


Hypertension ◽  
1992 ◽  
Vol 19 (1_Suppl) ◽  
pp. I78-I78 ◽  
Author(s):  
A. K. Gupta ◽  
R. V. Clark ◽  
K. A. Kirchner

1999 ◽  
Vol 276 (3) ◽  
pp. R790-R798 ◽  
Author(s):  
Ai-Ping Zou ◽  
Kasem Nithipatikom ◽  
Pin-Lan Li ◽  
Allen W. Cowley

This study determined the levels of adenosine in the renal medullary interstitium using microdialysis and fluorescence HPLC techniques and examined the role of endogenous adenosine in the control of medullary blood flow and sodium excretion by infusing the specific adenosine receptor antagonists or agonists into the renal medulla of anesthetized Sprague-Dawley rats. Renal cortical and medullary blood flows were measured using laser-Doppler flowmetry. Analysis of microdialyzed samples showed that the adenosine concentration in the renal medullary interstitial dialysate averaged 212 ± 5.2 nM, which was significantly higher than 55.6 ± 5.3 nM in the renal cortex ( n = 9). Renal medullary interstitial infusion of a selective A1antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 300 pmol ⋅ kg−1 ⋅ min−1, n = 8), did not alter renal blood flows, but increased urine flow by 37% and sodium excretion by 42%. In contrast, renal medullary infusion of the selective A2 receptor blocker 3,7-dimethyl-1-propargylxanthine (DMPX; 150 pmol ⋅ kg−1 ⋅ min−1, n = 9) decreased outer medullary blood flow (OMBF) by 28%, inner medullary blood flows (IMBF) by 21%, and sodium excretion by 35%. Renal medullary interstitial infusion of adenosine produced a dose-dependent increase in OMBF, IMBF, urine flow, and sodium excretion at doses from 3 to 300 pmol ⋅ kg−1 ⋅ min−1( n = 7). These effects of adenosine were markedly attenuated by the pretreatment of DMPX, but unaltered by DPCPX. Infusion of a selective A3receptor agonist, N 6-benzyl-5′-( N-ethylcarbonxamido)adenosine (300 pmol ⋅ kg−1 ⋅ min−1, n = 6) into the renal medulla had no effect on medullary blood flows or renal function. Glomerular filtration rate and arterial pressure were not changed by medullary infusion of any drugs. Our results indicate that endogenous medullary adenosine at physiological concentrations serves to dilate medullary vessels via A2 receptors, resulting in a natriuretic response that overrides the tubular A1 receptor-mediated antinatriuretic effects.


1982 ◽  
Vol 170 (4) ◽  
pp. 517-522
Author(s):  
Y. R. Barbella ◽  
J. N. D. Wurpel ◽  
W. B. Severs

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Ahmed El-Tahawy ◽  
Mohammad Mohammad ◽  
Magdy AbdSamee ◽  
Mohammad Al-Daydammony

Author(s):  
Sunishtha Singh Yadav ◽  
Vandana Chauhan ◽  
Vijeta Singh ◽  
Svenja Kohler

Cancer has been known as a devastating disease that takes thousands of lives every year. And since this is a heterogenous disease, standard treatments, like chemotherapy, radiation, and chemo-radio therapy, are effective in specific patient population subset only. Genetic differences play a very crucial role in defining cancer susceptibility and also in determining the drug's efficacy by affecting regulation, expression, and activity of drug metabolizing enzymes, drug transporters, and drug receptors. This genetic variability of the disease lends itself to the emerging field of precision or personalized medicine. There are some specific ways of acquiring data for precision or personalized medicine approach like genome wide association scan (GWAS). This is basically identification and scanning of biomarkers throughout the complete DNA/genome of several individuals to study any type of genetic variations which are linked with any form of cancer.


Sign in / Sign up

Export Citation Format

Share Document